Dr. Lal PathLabs announced its Q2 FY26 earnings, showcasing a revenue increase of 10.7% to ₹731 crore. EBITDA grew by 10.8%, reaching ₹224 crore, and PAT increased by 16.4% to ₹152 crore. The company also highlighted network expansion, including an increase in Patient Service Centers and lab capabilities, as well as strong growth in its Swasthfit contribution, which is now at 26%.
Financial Performance
Dr. Lal PathLabs reported a strong financial performance for Q2 FY26:
- Revenue: ₹731 crore, up 10.7% year-over-year
- EBITDA: ₹224 crore, a 10.8% increase
- PAT: ₹152 crore, reflecting a 16.4% growth
The company serviced 8.2 million patients, a 5.0% increase, and processed 25.4 million samples, up 10.3%.
Key Performance Highlights
Revenue reached ₹1400 crore in FH26, an 11.0% increase compared to the previous year, driven by sample volume growth of 10.4%. This growth was fueled by network expansion in core metro markets and deeper penetration into Tier 3 and 4 cities.
EBITDA increased by 11.8% year-over-year, supported by sustained volume growth, network expansion, and an efficient hub-and-spoke model.
The board approved a dividend of 70%, which is ₹7 per share, and a bonus issue in the ratio of 1:1.
Network Expansion
Dr. Lal PathLabs has expanded its network:
- Clinical Laboratories: Increased to 298.
- Patient Service Centers (PSCs): Expanded to 6,607.
- Pick-up Points (PUPs): Reached 12,365.
Strategic Initiatives
The company remains focused on expanding its high-complexity testing capabilities, including Genomics and Oncology, and is increasing the application of AI in its operations.
Digital and automation initiatives are central to improving operational efficiency and patient experience.
Future growth will be driven by geographic expansion, portfolio innovation, and digital enablement.
Quality and Accreditations
Dr. Lal PathLabs maintains high-quality standards and has received accreditations from CAP and NABL, along with ISO certifications.
The company uses technology for real-time quality control monitoring.
Vision and Mission
The company’s vision is to be the most trusted healthcare partner, enabling healthier lives. Its mission is to be an undisputed market leader by providing accessible, affordable, timely, and quality healthcare.
Source: BSE
